Cell-Free Culture Supernatant of Bifidobacterium breve CNCM I-4035 Decreases Pro-Inflammatory Cytokines in Human Dendritic Cells Challenged with Salmonella typhi through TLR Activation

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Bermudez Brito, Miriam ^a   Muñoz Quezada, Sergio ^a   Gomez Llorente, Carolina ^a   Matencio, Esther ^b   Bernal, Maria J ^b   Romero, Fernando ^b   Gil, Angel ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b Hero Group   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; RANTES; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM BREVE; CELL FREE SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOMODULATION; IMMUNOREACTIVITY; INFANT; INNATE IMMUNITY; INTESTINE CELL; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NORMAL HUMAN; PROTEIN EXPRESSION; SALMONELLA TYPHI; SIGNAL TRANSDUCTION; TOLL LIKE RECEPTOR 1 GENE; TOLL LIKE RECEPTOR 2 GENE; TOLL LIKE RECEPTOR 3 GENE; TOLL LIKE RECEPTOR 4 GENE; TOLL LIKE RECEPTOR 5 GENE; TOLL LIKE RECEPTOR 9 GENE; TOLLIP GENE; TRANSCRIPTION REGULATION; UPREGULATION;

BIFIDOBACTERIUM; CASPASE 8; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; CYTOKINES; DENDRITIC CELLS; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PROBIOTICS; SALMONELLA TYPHI; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 9;

EID: 84874853479     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059370     Document Type: Article

References (58)

1. Verbeek R, Bsibsi M, Plomp A, van Neerven RJ, te Biesebeke R, et al. (2010) Late rather than early responses of human dendritic cells highlight selective induction of cytokines, chemokines and growth factors by probiotic bacteria. Benef. Microbes. 1: 109-19.
2. Guarner F, Malaguelada JR, (2003) Gut flora in health and disease. Lancet. 361: 512-519.
3. Collado MC, Isolauri E, Salminen S, Sanz Y, (2009) The impact of probiotic on gut health. Curr. Drug. Metab. 10: 68-78.
4. Bermudez-Brito M, Plaza-Díaz J, Muñoz-Quezada S, Gomez-Llorente C, Gil A, (2012) Mechanisms of action of probiotics. Ann. Nutr. Metab. 61: 160-174.
5. Yan F, Polk DB, (2011) Probiotics and immune health. Curr. Opin. Gastroenterol. 27: 496-501.
6. Huang JS, Bousvaros A, Lee JW, Diaz A, Davidson EJ, (2002) Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig. Dis. Sci. 47: 2625-34.
7. Pelletier X, Laure-Boussuge S, Donazzolo Y, (2001) Hydrogen excretion upon ingestion of dairy products in lactose-intolerant male subjects: importance of the live flora. Eur. J. Clin. Nutr. 55: 509-12.
8. Woodard GA, Encarnacion B, Downey JR, Peraza J, Chong K, et al. (2009) Probiotics improve outcomes after Roux-en-Y gastric bypass surgery: a prospective randomized trial. J. Gastrointest. Surg. 13: 1198-204.
9. Karska-Wysocki B, Bazo M, Smoragiewicz W, (2010) Antibacterial activity of Lactobacillus acidophilus and Lactobacillus casei against methicillin-resistant Staphylococcus aureus (MRSA). Microbiol. Res. 165: 674-86.
10. Liong MT, (2008) Safety of probiotics: translocation and infection. Nutr. Rev. 66: 192-202.
11. Rafter J, Bennett M, Caderni G, Clune Y, Hughes R, et al. (2007) Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am. J. Clin. Nutr. 85: 488-96.
12. Moayyedi P, Ford AC, Talley NJ, Cremonini F, Foxx-Orenstein AE, et al. (2010) The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut. 59: 325-32.
13. Golowczyc MA, Mobili P, Garrote GL, Abraham AG, De Antoni GL, (2007) Protective action of Lactobacillus kefir carrying S-layer protein against Salmonella enterica serovar enteritidis. Int. J. Food. Microbiol. 118: 264-73.
14. Ohnmacht C, Pullner A, King SB, Drexler I, Meier S, et al. (2009) Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J. Exp. Med. 206: 549-59.
15. Kushwah R, Hu J, (2011) Role of dendritic cells in the induction of regulatory T cells. Cell. Biosci. 1: 20.
16. Rizzello V, Bonaccorsi I, Dongarrà ML, Fink LN, Ferlazzo G, (2011) Role of natural killer and dendritic cell crosstalk in immunomodulation by commensal bacteria probiotics. J. Biomed. Biotechnol. 2011: 473097.
17. Gómez-Llorente C, Muñoz S, Gil A, (2010) Role of Toll-like receptors in the development of immunotolerance mediated by probiotics. Proc. Nutr. Soc. 69: 381-9.
18. Hua MC, Lin TY, Lai MW, Kong MS, Chang HJ, et al. (2010) Probiotic Bio-Three induces Th1 and anti-inflammatory effects in PBMC and dendritic cells. World. J. Gastroenterol. 16: 3529-40.
19. Kelsall BL, Rescigno M, (2004) Mucosal Dendritic Cells in Immunity and Inflammation. Nat. Immunol. 5: 1091-5.
20. Tsilingiri K, Barbosa T, Penna G, Caprioli F, Sonzogni A, et al. (2012) Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model. Gut. 61: 1007-15.
21. Ayehunie S, Snell M, Child M, Klausner M, (2009) A plasmacytoid dendritic cell (CD123+/CD11c-) based assay system to predict contact allergenicity of chemicals. Toxicology. 264: 1-9.
22. Vieites Fernández JM, Muñoz Quezada S, Llamas Company I, Maldonado Lozano J, Romero Braquehais R,et al. (2010) PCT AX090006WO.
23. Muñoz-Quezada S, Chenoll E, Vieites Fernández JM, Genovés S, Maldonado J, et al. (2013) Isolation, identification and characterization of three novel probiotic strains (Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036) from faeces of exclusively breast milk fed infants. Br. J. Nutr. 109: S51-62.
24. Muñoz-Quezada S, Bermudez-Brito M, Chenoll E, Genovés S, Gómez-Llorente C, et al. (2013) Competitive inhibition of three novel bacteria isolated from faeces of breast milk-fed infants against selected enteropathogens. Br. J. Nutr. 109: S63-9.
25. Stagg AJ, Hart AL, Knight SC, Kamm MA, (2003) The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria. Gut. 52: 1522-9.
26. Evrard B, Coudeyras S, Dosgilbert A, Charbonnel N, Alamé J, et al. (2011) Dose-dependent immunomodulation of human dendritic cells by the probiotic Lactobacillus rhamnosus Lcr35. PLoS One 6: e18735.
27. Boyle RJ, Robins-Browne RM, Tang ML, (2006) Probiotic use in clinical practice: what are the risks? Am. J. Clin. Nutr. 83: 1256-1264.
28. Young SL, Simon MA, Baird MA, Tannock GW, Bibiloni R, et al. (2004) Bifidobacterial species differentially affect expression of cell surface markers and cytokines of dendritic cells harvested from cord blood. Clin. Diagn. Lab. Immunol. 11: 686-690.
29. López P, Gueimonde M, Margolles A, Suárez A, (2010) Distinct Bifidobacterium strains drive different immune responses in vitro. Int. J. Food. Microbiol. 138: 157-165.
30. Hoarau C, Lagaraine C, Martin L, Velge-Roussel F, Lebranchu Y, (2006) Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a Toll-like receptor 2 pathway. J. Allergy. Clin. Immunol. 117: 696-702.
31. Bermudez-Brito M, Muñoz-Quezada S, Gomez-Llorente C, Matencio E, Bernal MJ, et al. (2012) Human intestinal dendritic cells decrease cytokine release against Salmonella infection in the presence of Lactobacillus paracasei upon TLR activation. PloS One 7: e43197.
32. Weiss G, Christensen HR, Zeuthen LH, Vogensen FK, Jacobsen M, et al. (2011) Lactobacilli and bifidobacteria induce differential interferon-β profiles in dendritic cells. Cytokine. 56: 520-30.
33. Turroni F, Van Sinderen D, Ventura M (2011) Genomics and ecological overview of the genus Bifidobacterium. Int. J. Food. Microbiol. 149; 37-44.
34. Borchers AT, Selmi C, Meyers FJ, Keen CL, Gershwin ME, (2009) Probiotics and immunity. J. Gastroenterol. 44: 26-46.
35. Madsen K, (2006) Probiotics and the immune response. J. Clin. Gastroenterol. 40: 232-4.
36. Aujla SJ, Dubin PJ, Kolls JK, (2007) Th17 cells and mucosal host defense. Semin Immunol. 19: 377-82.
37. Dubin PJ, Kolls JK, (2008) Th17 cytokines and mucosal immunity. Immunol Rev. 226: 160-71.
38. Medina M, Izquierdo E, Ennahar S, Sanz Y, (2007) Differential immunomodulatory properties of Bifidobacterium longum strains: relevance to probiotic selection and clinical applications. Clin. Exp. Immunol. 150: 531-8.
39. Marie JC, Letterio JJ, Gavin M, Rudensky AY, (2005) TGF-beta 1 maintains suppressor function and Foxp3 expression in CD4+ CD25+ regulatory T cells. J Exp Med. 201: 1061-7.
40. Nakamura K, Kitani A, Fuss I, Pedersen A, Harada N, et al. (2004) TGF-beta 1 plays an important role in the mechanism of CD4+ CD25+ regulatory T cell activity in both humans and mice. J Immunol. 172: 834-4240.
41. Strobl H, Knapp W, (1999) TGF-beta 1 regulation of dendritic cells. Microbes Infect 1: 1283-90.
42. Plantinga TS, van Maren WW, van Bergenhenegouwen J, Hameetman M, Nierkens S, et al. (2011) Differential Toll-like receptor recognition and induction of cytokine profile by Bifidobacterium breve and Lactobacillus strains of probiotics. Clin. Vaccine. Immunol. 18: 621-8.
43. Hiramatsu Y, Satho T, Irie K, Shiimura S, Okuno T, et al. (2012) Differences in TLR9-dependent inhibitory effects of H(2)O(2)-induced IL-8 secretion and NF-kappa B/I kappa B-alpha system activation by genomic DNA from five Lactobacillus species. Microbes Infect.(2012) pii: S1286-4579(12)00274-2.
44. Ghadimi D, Vrese Md, Heller KJ, Schrezenmeir J, (2010) Effect of natural commensal-origin DNA on toll-like receptor 9 (TLR9) signaling cascade, chemokine IL-8 expression, and barrier integritiy of polarized intestinal epithelial cells. Inflamm Bowel Dis. 16: 410-27.
45. Lavelle EC, Murphy C, O'Neill LA, Creagh M, (2010) The role of TLRs, NLRs, and RLRs in mucosal innate immunity and homeostasis. Mucosal. Immunol. 3: 17-28.
46. Kaji R, Kiyoshima-Shibata J, Nagaoka M, Nanno M, Shida K, (2010) Bacterial teichoic acids reverse predominant IL-12 production induced by certain Lactobacillus strains into predominant IL-10 production via TLR2-dependent ERK activation in macrophages. J Immunol. 184: 3505-13.
47. Zeuthen LH, Fink LN, Frøkiaer H, (2008) Toll-like receptor 2 and nucleotide-binding oligomerization domain-2 play divergent roles in the recognition of gut-derived lactobacilli and bifidobacteria in dendritic cells. Immunology. 124: 489-502.
48. Vizoso Pinto MG, Rodriguez Gomez M, Seifert S, Watzl B, Holzapfel WH, et al. (2009) Lactobacilli stimulate the innate immune response and modulate the TLR expression of HT29 intestinal epithelial cells in vitro. Int. J. Food. Microbiol. 33: 86-93.
49. Tao Y, Drabik KA, Waypa TS, Musch MW, Alverdy JC, et al. (2006) Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells. Am. J. Physiol. 290: 1018-30.
50. Kim YG, Ohta T, Takahashi T, Kushiro A, Nomoto K, et al. (2006) Probiotic Lactobacillus casei activates innate immunity via NF-kappaB and p38 MAP kinase signaling pathways. Microbes. Infect. 8: 994-1005.
51. Voltan S, Castagliuolo I, Elli E, Longo S, Brun P, et al. (2007) Aggregating phenotype in Lactobacillus crispatus determines intestinal colonization and TLR2 and TLR4 modulation in murine colonic mucosa. Clin. Vaccine. Immunol. 14: 1138-48.
52. Uematsu S, Fujimoto K, Jang MH, Yang BG, Jung YJ, et al. (2008) Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. Nat. Immunol. 9: 769-76.
53. Feng T, Elson CO, Cong Y, (2011) Treg cell-Ig A axis in maintenance of host immune homeostasis with microbiota. Int. Immunopharmacol. 11: 589-592.
54. Hansen J, Gulati A, Sartor RB, (2010) The role of mucosal immunity and host genetics in defining intestinal commensal bacteria. Curr. Opin. Gastroenterol. 26: 564-71.
55. Bulut Y, Faure E, Thomas L, Equils O, Arditi M, (2001) Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J. Immunol. 167: 987-94.
56. Zhang G, Ghosh S, (2002) Negative regulation of toll-like receptor-mediated signalling by Tollip. J. Biol. Chem. 277: 7059-65.
57. Burns K, Clatworthy J, Martin L, Martinon F, Plumpton C, et al. (2000) Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat Cell Biol. 2: 346-51.
58. Adams CA, (2010) The probiotic paradox: live and dead cells are biological response modifiers. Nutr. Res. Rev. 23: 37-46.